Highly efficient neutralization of HIV with recombinant CD4-immunoglobulin molecules

[1]  H. Mitsuya,et al.  Designing CD4 immunoadhesins for AIDS therapy , 1989, Nature.

[2]  F. Oliveri,et al.  Solubilizing the T-cell receptor--problems in solution. , 1989, Immunology today.

[3]  R. Siliciano,et al.  Analysis of host-virus interactions in AIDS with anti-gp120 T cell clones: Effect of HIV sequence variation and a mechanism for CD4+ cell depletion , 1988, Cell.

[4]  A. Lanzavecchia,et al.  T cells can present antigens such as HIV gp120 targeted to their own surface molecules , 1988, Nature.

[5]  D. Tyler,et al.  CELLULAR ANTI-GP120 CYTOLYTIC REACTIVITIES IN HIV-1 SEROPOSITIVE INDIVIDUALS , 1988, The Lancet.

[6]  G. Winter,et al.  The binding site for C1q on IgG , 1988, Nature.

[7]  D. Burton,et al.  Localization of the binding site for the human high-affinity Fc receptor on IgG , 1988, Nature.

[8]  W. Lüke,et al.  Soluble CD4 molecules neutralize human immunodeficiency virus type 1 , 1988, Nature.

[9]  R. Axel,et al.  soluble form of CD4 (T4) protein inhibits AIDS virus infection , 1988, Nature.

[10]  R. Siliciano,et al.  A soluble CD4 protein selectively inhibits HIV replication and syncytium formation , 1988, Nature.

[11]  B. Walker,et al.  HIV infection is blocked in vitro by recombinant soluble CD4 , 1988, Nature.

[12]  S. Marsters,et al.  Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen. , 1987, Science.

[13]  G. Nakamura,et al.  Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor , 1987, Cell.

[14]  A J Langlois,et al.  Human T-cell lymphotropic virus IIIB glycoprotein (gp120) bound to CD4 determinants on normal lymphocytes and expressed by infected cells serves as target for immune attack. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Robin A. Weiss,et al.  The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain , 1986, Cell.

[16]  T. Copeland,et al.  Shedding and interspecies type sero-reactivity of the envelope glycopolypeptide gp120 of the human immunodeficiency virus. , 1986, The Journal of general virology.

[17]  K. Steimer,et al.  Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein , 1986, Nature.

[18]  S. Wain-Hobson,et al.  Genetic variability of the AIDS virus: Nucleotide sequence analysis of two isolates from African patients , 1986, Cell.

[19]  Hans Wolf,et al.  Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS , 1986, Cell.

[20]  I. Mckenzie,et al.  Partial primary structure of the T4 antigens of mouse and sheep: assignment of intrachain disulfide bonds. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Kearney,et al.  Posttranslational association of immunoglobulin heavy chain binding protein with nascent heavy chains in nonsecreting and secreting hybridomas , 1986, The Journal of cell biology.

[22]  K. Karjalainen,et al.  A novel approach for preparing anti‐T cell receptor constant region antibodies , 1986, European journal of immunology.

[23]  J. Sodroski,et al.  Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity , 1986, Nature.

[24]  G. Pauli,et al.  LOSS OF ENVELOPE ANTIGENS OF HTLV-III/LAV, A FACTOR IN AIDS PATHOGENESIS? , 1985, The Lancet.

[25]  J. Mcdougal,et al.  Cellular tropism of the human retrovirus HTLV-III/LAV. I. Role of T cell activation and expression of the T4 antigen. , 1985, Journal of immunology.

[26]  R. Redfield,et al.  Genomic diversity of human T-lymphotropic virus type III (HTLV-III). , 1985, Science.

[27]  M. Gonda,et al.  Genomic diversity of the acquired immune deficiency syndrome virus HTLV-III: different viruses exhibit greatest divergence in their envelope genes. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[28]  R. Gallo,et al.  Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. , 1984, Science.

[29]  N. Yamamoto,et al.  Sera from adult T-cell leukemia patients react with envelope and core polypeptides of adult T-cell leukemia virus. , 1984, Virology.

[30]  Luc Montagnier,et al.  T-lymphocyte T4 molecule behaves as the receptor for human retrovirus  LAV , 1984, Nature.

[31]  M. Greaves,et al.  The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus , 1984, Nature.

[32]  M. Wabl,et al.  Immunoglobulin heavy chain binding protein , 1983, Nature.

[33]  Y. Ohtsuki,et al.  Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells , 1981, Nature.

[34]  J. Deisenhofer.  Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution. , 1981, Biochemistry.

[35]  J. Brouet,et al.  Heavy Chain Diseases: Current Findings and Concepts , 1979, Immunological reviews.